DOLF researchers announce initiation of a major a new clinical trial of treatments for onchocerciasis in Liberia. The study will compare the safety and efficacy of three new combination treatments with a reference treatment of albendazole plus ivermectin.
The DOLF Project has Initiated a Clinical Trial of New Treatments for Onchocerciasis in Liberia (Links to an external site)
